Antabio announces further progress towards the treatment of antibiotic-resistant infections

Antabio to participate in Nature’s Webcast on Combating Antibiotic Resistance on March 9

Antabio signs the Industry call for new antimicrobial business models presented at the World Economic Forum, Davos

ANTABIO receives €4 Million to develop new drugs to treat chronic infections in Cystic Fibrosis patients

Antabio is now a member of the newly launched BEAM Alliance

Antabio awarded EUR 1 million funding from Bpifrance to support the discovery of New Gram-Negative Anti-Infective Agents

Antabio receives the Tremplin Entreprises 2015 Award

Antabio receives funding from the Midi-Pyrénées Region to support the expansion of its R&D capabilities

Antabio awardee of the “Concours Mondial de l’Innovation 2030” Worldwide Innovation Challenge

Antabio profiled in the June 2014 issue of Nature Biopharma Dealmakers on infectious diseases